相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of apremilast for Behcet's syndrome: a real-life single-centre Italian experience
Giacomo De Luca et al.
RHEUMATOLOGY (2020)
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis
Elisabetta Miserocchi et al.
CLINICAL RHEUMATOLOGY (2020)
Efficacy of TNFα inhibitors for refractory vascular Behcet's disease: A multicenter observational study of 27 patients and a review of the literature
Aysun Aksoy et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)
Positioning of apremilast in treatment of Behcet's disease
Mitsuhiro Takeno
MODERN RHEUMATOLOGY (2020)
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behcet's phenotype: a multicentre study
Filippo Fagni et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
A pilot study of tofacitinib for refractory Behcet's syndrome
Jinjing Liu et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Behcet's Disease, and the Role of TNF-α and TNF-α Blockers
Tim van der Houwen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effectiveness of tocilizumab in Behcet's disease: A systematic literature review
Mitsuhiro Akiyama et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2019)
Efficacy of the anti-IL 17 secukinumab in refractory Behcet's syndrome: A preliminary study
Gerardo Di Scala et al.
JOURNAL OF AUTOIMMUNITY (2019)
Behcet's disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes
Sergio Burillo-Sanz et al.
SCIENTIFIC REPORTS (2019)
Long-Term Outcome of Ustekinumab Therapy for Behcet's Disease
Adrien Mirouse et al.
ARTHRITIS & RHEUMATOLOGY (2019)
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
Dennis G. McGonagle et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis
P. Bauermann et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behcet's Disease: National Multicenter Study of 177 Cases
Belen Atienza-Mateo et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Trial of Apremilast for Oral Ulcers in Behcet's Syndrome
Guelen Hatemi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Association of Functional Polymorphisms of KIR3DL1/DS1 With Behcet's Disease
Angel Castano-Nunez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease
Ippei Miyagawa et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behcet's disease: a large-scale, long-term postmarketing surveillance in Japan
Shigeaki Ohno et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Immunopathogenesis of Behcet's Disease
Bainan Tong et al.
FRONTIERS IN IMMUNOLOGY (2019)
2018 update of the EULAR recommendations for the management of Behcet's syndrome
Gulen Hatemi et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Behcet's disease: New insights into pathophysiology, clinical features and treatment options
Antonio Greco et al.
AUTOIMMUNITY REVIEWS (2018)
Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients
Cemile Sonmez et al.
CLINICAL RHEUMATOLOGY (2018)
Behcet syndrome: a contemporary view
Hasan Yazici et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behcet's Syndrome A Retrospective Study of Seventy Patients With Vascular Involvement
Giacomo Emmi et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Mutational profile of rare variants in inflammasome-related genes in Behcet disease: A Next Generation Sequencing approach
Sergio Burillo-Sanz et al.
SCIENTIFIC REPORTS (2017)
In vitro evaluation of gamma delta T cells regulatory function in Behcet's disease patients and healthy controls
Antonio Clemente Ximenis et al.
HUMAN IMMUNOLOGY (2016)
Genetic Analysis with the Immunochip Platform in Behcet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci
Lourdes Ortiz-Fernandez et al.
PLOS ONE (2016)
Behcet syndrome: from pathogenesis to novel therapies
Gianluigi Mazzoccoli et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: genetics
Michael J. Ombrello et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Variants of the IFI16 Gene Affecting the Levels of Expression of mRNA Are Associated with Susceptibility to Behcet Disease
Lourdes Ortiz-Fernandez et al.
JOURNAL OF RHEUMATOLOGY (2015)
'MHC-I-opathy'-unified concept for spondyloarthritis and Behcet disease
Dennis McGonagle et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study
Gulen Hatemi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Activation of the JAK/STAT pathway in Behcet's disease
A. Tulunay et al.
GENES AND IMMUNITY (2015)
Secretion of interleukin-17 by CD8+T cells expressing CD146 (MCAM)
Pradeep K. Dagur et al.
CLINICAL IMMUNOLOGY (2014)
Effects of Topical Janus Kinase Inhibition on Ocular Surface Inflammation and Immunity
William Stevenson et al.
CORNEA (2014)
Behcet's syndrome pathophysiology and potential therapeutic targets
Giacomo Emmi et al.
INTERNAL AND EMERGENCY MEDICINE (2014)
Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial
Fereydoun Davatchi et al.
Modern Rheumatology (2014)
Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease
Shigeru Iwata et al.
Modern Rheumatology (2014)
Toll-like receptor polymorphisms and vasculitis susceptibility: meta-analysis and systematic review
Gwan Gyu Song et al.
MOLECULAR BIOLOGY REPORTS (2013)
Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1
Yohei Kirino et al.
NATURE GENETICS (2013)
Behcet's Syndrome
Gulen Hatemi et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2013)
Expression of regulatory receptors on gamma delta T Cells and their cytokine production in Behcet's disease
Gunes Parlakgul et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2012)
Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behcet's disease
J. Shimizu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Long-Term Efficacy and Safety of Infliximab in the Treatment of Behcet's Disease
Maria Jose Capella et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2012)
Neurological manifestations of Behcet's disease: Evaluation of 40 patients treated by cyclophosphamide
E. H. Ait Ben Haddou et al.
REVUE NEUROLOGIQUE (2012)
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease
Fabiola Atzeni et al.
RHEUMATOLOGY (2012)
Adalimumab for the treatment of Behcet's disease: experience in 19 patients
Daniela Perra et al.
RHEUMATOLOGY (2012)
Behcet's disease: Successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis
Sabine Adler et al.
ARTHRITIS CARE & RESEARCH (2012)
Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy
Hiroshi Keino et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease
Chiara De Cassan et al.
JOURNAL OF CROHNS & COLITIS (2011)
Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Beh‡et's disease
Nadia Emi Aikawa et al.
RHEUMATOLOGY INTERNATIONAL (2011)
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behcet's disease refractory to standard immunosuppressive drugs
AnnaRita Giardina et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Anti-TNF Agents for Behcet's Disease: Analysis of Published Data on 369 Patients
Aikaterini Arida et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Pulmonary and Vascular Manifestations of Behcet Disease: Imaging Findings
Naim Ceylan et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Etiopathogenesis of Behcet's disease
Claudia Mendoza-Pinto et al.
AUTOIMMUNITY REVIEWS (2010)
Adalimumab treatment for life threatening pulmonary artery aneurysm in Behcet disease: a case report
Sung-Won Lee et al.
CLINICAL RHEUMATOLOGY (2010)
Clinical Experience with Adalimumab in the Treatment of Ocular Behcet Disease
Ahmed Bawazeer et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2010)
Azathioprine in Severe Uveitis of Behcet's Disease
D. Saadoun et al.
ARTHRITIS CARE & RESEARCH (2010)
Thromboembolic disease in vasculitis
Gunnar Tomassion et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Infliximab for the treatment of neuro-Behcet's disease: A case series and review of the literature
Nicolo Pipitone et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Efficacy of etanercept in the treatment of a patient with Behcet's disease
Valentina Curigliano et al.
CLINICAL RHEUMATOLOGY (2008)
Effect of infliximab in progressive Neuro-Behcet's syndrome
Hirotoshi Kikuchi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Autoimmunity vs autoinflammation in Behcet's disease:: do we oversimplify a complex disorder?
H. Direskeneli
RHEUMATOLOGY (2006)
CNS involvement occurs more frequently in patients with Behcet's disease under cyclosporin A (CSA) than under other medications -: results of a retrospective analysis of 117 cases
Ina Koetter et al.
CLINICAL RHEUMATOLOGY (2006)
Diversity of γδ T cells in patients with Behcet's disease is indicative of polyclonal activation
J. Freysdottir et al.
ORAL DISEASES (2006)
Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD
A. M. Dalghous et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2006)
T cell-regulated neutrophilic inflammation in autoinflammatory diseases
M Keller et al.
JOURNAL OF IMMUNOLOGY (2005)
Colchicine as first-choice therapy for recurrent pericarditis - Results of the CORE (COlchicine for REcurrent pericarditis) trial
M Imazio et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab)
JM Benitez-del-Castillo et al.
EYE (2005)
Cerebral venous thrombosis is associated with major vessel disease in Behcet's syndrome
R Tunc et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Pulmonary artery aneurysms in Behcet syndrome
V Hamuryudan et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Behcet's disease
SE Marshall
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2004)
Behcet's disease: a new target for anti-tumour necrosis factor treatment
PP Sfikakis
ANNALS OF THE RHEUMATIC DISEASES (2002)
HSP 60 expression in mucocutaneous lesions of Behcet's disease
T Ergun et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behcet's disease
YD Adler et al.
DERMATOLOGY (2001)
分享论文
